INTRODUCTION
Accessory spleen is a congenital anomaly in which splenic tissue is found outside the spleen. This anomaly usually occurs in the fifth week of intrauterine fetal development [1] . Accessory spleens occur in about 10% of normal population and can be found practically anywhere in the abdominal cavity. In the majority of cases they are localized in the splenic hilum, gastro-splenic ligament and greater omentum [2] . Less frequent localizations include gastric wall, small intestine, mesenterium, pancreas, even ovary and testicle [3] . Accessory spleens are in fact ectopic splenic tissue. They are usually asymptomatic and almost never require specific treatment, except in some hematologic disorders such as idiopathic thrombocytopenic purpura (ITP). Intrapancreatic accessory spleens (IPAS) are found in about 1,7% of the population and their intrapancreatic localization can be misleading in diagnostic procedures as well as in choosing the proper therapeutic approach. These lesions are usually present in CT/MRI findings as hypervascular, well-delimited lesions which can be easily misdiagnosed for a well differentiated pancreatic tumor, pancreatic neuroendocrine tumor (PNET), solid pseudo-papillary pancreatic neoplasm or even metastatic pancreatic tumor [4] . Therefore, the diagnosis is usually obtained only after histopathologic examination of the resected specimen since these patients frequently undergo pancreatic resection due to impossibility of excluding pancreatic neoplasm [5] . Although uncommon, intrapancreatic accessory spleen should be taken into consideration in the diagnostic algorithm for pancreatic lesions, especially since new and adequate diagnostic procedures can be of use in obtaining the right diagnosis and avoiding the unnecessary surgical intervention with all potential complications [6] .
CASE REPORT
A 70-year-old female was admitted to hospital for non-specific, dull epigastric pain and upper abdominal discomfort. Laboratory findings and tumor-marker serum levels (CA 19-9, CEA, CA 72-4) were within the reference range. Chromogranin A (CgA) serum level was slightly elevated. Abdominal ultrasound and multi-detector computed tomography (MDCT) revealed a well-delimited, hypervascular tumor-like lesion, 20×18 mm in size, located in the tail of the pancreas (Figures 1, 2 and 3). According to the imaging characteristics of the lesion and elevated serum CgA level, the lesion was interpreted as a non-functioning PNET and the decision for surgical procedure was made.
The patient was operated by the laparoscopic approach in the right lateral supine position (hanging spleen technique) which eases the access to the colon splenic flexure, spleen and tail of the pancreas. After complete mobilization of the colon, splenic flexure and entering the grater sac (omental bursa) through the gastro-colic ligament, anterior surface of the pancreatic body and tail was completely exposed. A dark reddish-brown in color tumorous lesion on the posterior side of the pancreatic tail was detected. The pancreatic tail was divided from blood vessels for splenic inferior pole and from splenic vein by cutting short pancreatic vein branches with an ultrasound harmonic knife. The tail of the pancreas was further mobilized toward the medial axis to the left lateral side of the superior mesenteric vein. Pancreatic transection was then performed at the level of the neck of the pancreas using an endoscopic stapling device (Endo GIA). No major bleeding from the resected surface of the pancreas or pancreatic juice leakage was observed. Laparoscopic distal pancreatectomy with preservation of the spleen was then completed. This was, in fact, the first ever laparoscopic pancreatic resection performed in the Clinical Centre of Serbia. The resected pancreas was placed in the endoscopic bag and removed through one of the ports on the anterior abdominal wall. The specimen was then sent to the pathologist for histopathologic examination (Figure 4 ). Macroscopically, the lesion was oval, encapsulated, nodelike, dark reddish-brown in color, 20 mm in size and resembling that of splenic tissue. Histopathologic analysis revealed the true nature of the lesion and the diagnosis of intrapancreatic accessory spleen was established ( Figure  5 ). Postoperative course was uneventful and the patient was discharged from hospital after six days. One year after surgery, the patient is well and disease-free.
DISCUSSION
Although the intrapancreatic accessory spleen is considered as uncommon, Halpert and Gyorkey [3] have found 364 cases on 3,000 autopsies with 17% of them localized in the tail of the pancreas. Considering the benign nature of the lesion and frequent performance of unnecessary surgical procedures, it is important to obtain the correct diagnosis [7] .
There are less than 40 cases of IPAS published in the English literature to date. Vast majority of these patients underwent pancreatic resection as IPAS were misdiagnosed for pancreatic tumor, or PNET as in our case. Uchiyama et al. [8] published a case report and review of the literature in 2008 showing 11 patients with IPAS treated with pancreatic resections. In 9 cases IPAS was interpreted as non-functioning PNET, in 1 case as exocrine pancreatic tumor while only 1 patient had indication for surgery since the ITP was present along with IPAS. Lehtinen et al. [9] found, analyzed and published a report on 25 patients with IPAS in 2013 including those who were not treated with surgery. Beside the ITP, other spleen conditions and disorders may rise as well in the accessory spleen. There are several published cases of epidermoid cysts in resected IPAS and they were interpreted preoperatively as pancreatic cystadenomas [10, 11] .
IPAS is most commonly detected by MDCT or MRI imaging techniques. On MDCT, IPAS is usually presented as a hypervascular, homogeneous, well-delimited, tumorlike lesion, and usually less than 2 cm in size. MRI findings typically show weak attenuation in T1 and strong attenuation in T2 sequence [8] . These findings can be misleading as they are typical in PNET and not only in IPAS. In addition, 45-60% of PNET are non-functioning tumors and normal hormone serum level does not necessary imply the benign nature of the disease. Somatostatin receptor scintigraphy (Octreoscan) diagnostic value is also limited since splenic tissue is also known for somatostatin receptors expression [12] . Therefore, the differential diagnosis between IPAS and PNET remains challenging. There are few recommendations by different authors found in the literature concerning additional diagnostic procedures in effort to obtain a more precise diagnosis. Ota et al. [13] have proposed single photon emission computed tomography (SPECT) using red blood cells marked with technetium 99. Kim et al. [14] have confirmed the diagnostic value of SPECT and proposed SPIO (superparamagnetic iron oxide) enhanced MRI as even more precise diagnostic procedure. Other authors have pointed out the significance of contrast enhanced US, CT angiography and endoscopic US (EUS) with fine needle biopsy [15, 16, 17] .
In a case of asymptomatic, well-delimited, tumor-like lesion in the pancreatic tail which is smaller than 3 cm in size, IPAS should be taken into consideration. Thorough diagnostic procedures should be performed in order to exclude other lesions such as PNET, mucinous cystic neoplasms (MCN), solid pseudo-papillary tumor or pancreatic metastatic tumor. Once established, the diagnosis of IPAS precludes surgical treatment of the patient. If malignant nature of the lesion is still suspected after conducting all available diagnostic methods, surgical treatment is indicated.
